Catalyst Pharmaceuticals (CPRX) Earnings Date, Estimates & Call Transcripts $22.80 +0.75 (+3.40%) As of 04/14/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Catalyst Pharmaceuticals Earnings Summary Upcoming Q3 Earnings DateMay. 6After Market ClosesEstimatedConsensus EPS (Aug. 7) $0.39 Actual EPS (Aug. 7) $0.52 Beat By $0.13 Actual Revenue (Aug. 7) $122.71MCatalyst Pharmaceuticals issued Q2 2024 earnings on August 7, 2024, reporting an EPS of $0.52, which beat analysts' consensus estimates of $0.39 by $0.13. Quarterly revenue was reported to be $122.71 million, above the consensus estimate of $111.76 million. With a trailing EPS of $1.31 and a P/E Ratio of 19.32, Catalyst Pharmaceuticals' earnings are expected to grow 12.11% next year, from $1.90 to $2.13 per share. Q2 2024 Earnings ResourcesQ2 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)CPRX Upcoming EarningsCatalyst Pharmaceuticals' next earnings date is estimated for Tuesday, May 6, 2025, based on past reporting schedules. Powered by Get Catalyst Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Catalyst Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCPRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CPRX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Catalyst Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251$0.49$0.49$0.49Q2 20251$0.51$0.51$0.51Q3 20251$0.49$0.49$0.49Q4 20251$0.53$0.53$0.53FY 20254$2.02$2.02$2.02Q1 20261$0.57$0.57$0.57Q2 20261$0.55$0.55$0.55Q3 20261$0.57$0.57$0.57Q4 20261$0.57$0.57$0.57FY 20264$2.26$2.26$2.26 Remove Ads Catalyst Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)--------8/7/2024Q2 2024$0.39$0.52+$0.13$0.71$111.76M$122.71M5/8/2024Q1 2024$0.31$0.31-$0.43$97.24M$98.51M2/28/2024Q4 2023$0.45$0.49+$0.04$0.67$105.78M$110.57M11/8/2023Q3 2023-$0.26-$0.26--$0.23$100.17M$102.69M8/9/2023Q2 2023$0.25$0.33+$0.08$0.33$92.77M$99.58M5/10/2023Q1 2023$0.30$0.26 -$0.04$0.26$83.04M$85.37M Catalyst Pharmaceuticals Earnings - Frequently Asked Questions When is Catalyst Pharmaceuticals's earnings date? Catalyst Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on CPRX's earnings history. What guidance has Catalyst Pharmaceuticals issued on next quarter's earnings? Catalyst Pharmaceuticals issued an update on its FY 2025 earnings guidance on Wednesday, February, 26th. The company issued revenue guidance of $545.0 million-$565.0 million, compared to the consensus revenue estimate of $558.1 million. Did Catalyst Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Catalyst Pharmaceuticals (NASDAQ:CPRX) reported $0.52 earnings per share (EPS) to beat the analysts' consensus estimate of $0.39 by $0.13. Learn more on analysts' earnings estimate vs. CPRX's actual earnings. How can I listen to Catalyst Pharmaceuticals's earnings conference call? The conference call for Catalyst Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Catalyst Pharmaceuticals's conference call transcript? The conference call transcript for Catalyst Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Catalyst Pharmaceuticals generate each year? Catalyst Pharmaceuticals (NASDAQ:CPRX) has a recorded annual revenue of $491.73 million. How much profit does Catalyst Pharmaceuticals generate each year? Catalyst Pharmaceuticals (NASDAQ:CPRX) has a recorded net income of $71.41 million. CPRX has generated $1.31 earnings per share over the last four quarters. What is Catalyst Pharmaceuticals's price-to-earnings ratio? Catalyst Pharmaceuticals (NASDAQ:CPRX) has a trailing price-to-earnings ratio of 19.32 and a forward price-to-earnings ratio of 12.00. The price/earnings-to-growth ratio is 3.31. What is Catalyst Pharmaceuticals's EPS forecast for next year? Catalyst Pharmaceuticals's earnings are expected to grow from $1.90 per share to $2.13 per share in the next year, which is a 12.11% increase. More Earnings Resources from MarketBeat Related Companies RDY Earnings MRNA Earnings VTRS Earnings QGEN Earnings ASND Earnings ROIV Earnings LNTH Earnings TGTX Earnings RVMD Earnings BBIO Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Remove Ads This page (NASDAQ:CPRX) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catalyst Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Catalyst Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CPRX Stock Free CPRX Stock Alerts